Shirley Maria Edward, MD
Internal Medicine · Fremont
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
- Since medical school
- 10 years
- Graduated 2016
Offices
2 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Edward’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A155899 · Current
Licensed to practise in California · since 2018 · expires 2028-05-31 · University of Southern California Keck School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Internal Medicine
Original Medicare doctor bills
$28,950
Medicare paid this office $28,950 for 135 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 63 | $10,950 | $111 |
| Short return visit (20+ min) | 58 | $5,877 | $81 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 36 | $5,588 | $155 |
Who their Medicare patients are
135 Original Medicare patients in 2024. Average age 73 · Under 65 9% · 85 and older 10% · Women 70% · Also on Medicaid 19% · Health risk score 1.06. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 64% · Diabetes 38% · Coronary heart disease 17% · Chronic kidney disease 15% · Depression 15% · Cancer 14% · Heart failure 9% · Atrial fibrillation 8%.
The office billed $79,124, Medicare allowed $36,464 and paid $28,950; for 277 services of 28 kinds; $2,063 of it was for drugs given in the office and $26,887 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 135 | 277 | 73 | 1.06 | $79,124 | $28,950 |
| 2023 | 214 | 394 | 75 | 0.91 | $110,264 | $40,270 |
| 2022 | 199 | 426 | 75 | 1.01 | $112,275 | $40,822 |
| 2021 | 135 | 310 | 72 | 1.08 | $82,463 | $30,522 |
| 2020 | 99 | 213 | 72 | 1.22 | $51,506 | $17,179 |
| 2019 | 44 | 64 | 77 | 1.47 | $15,891 | $5,811 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
| Return visit (30+ min) | 99 | $15,506 | $112 |
| Short return visit (20+ min) | 104 | $9,164 | $73 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 44 | $6,886 | $157 |
| Transitional care management services for problem of at least moderate complexity | 17 | $3,596 | $200 |
2022: 5 services
| Return visit (30+ min) | 124 | $21,008 | $108 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 40 | $6,258 | $156 |
| Short return visit (20+ min) | 68 | $6,127 | $78 |
| Short return visit | 11 | $545 | $50 |
| Administration of influenza virus vaccine | 11 | $402 | $37 |
2021: 6 services
| Return visit (30+ min) | 79 | $15,390 | $110 |
| Short return visit (20+ min) | 45 | $3,604 | $74 |
| Transitional care management services for problem of at least moderate complexity | 11 | $3,356 | $197 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 22 | $3,168 | $144 |
| Influenza vaccine split virus, preservative free | 14 | $914 | $65 |
| Administration of influenza virus vaccine | 14 | $293 | $21 |
2020: 4 services
| Return visit (30+ min) | 50 | $6,659 | $91 |
| Short return visit (20+ min) | 29 | $2,126 | $64 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 15 | $2,068 | $138 |
| New patient visit (30+ min) | 23 | $1,430 | $62 |
2019: 1 service
| Return visit (30+ min) | 29 | $2,896 | $100 |
Drugs they prescribed that Part D paid
$69,745
Pharmacies billed $69,745 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 1% of their Part D prescriptions (12 of 1,005) in 2024. Above the middle of the specialty; the typical internal medicine clinician is at 1%.
882 generic and fewer than 11 brand-name prescriptions · $69,745 in drug cost · 40 antibiotic prescriptions to 26 people · 11 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 25 | $37,099 | $1,484 |
| Synthroid | 12 | $1,051 | $88 |
| Atorvastatin | 110 | $907 | $8 |
| Losartan | 41 | $683 | $17 |
| Levothyroxine | 52 | $665 | $13 |
See all 26 drugs
| Eliquis | 25 | $37,099 | $1,484 |
| Synthroid | 12 | $1,051 | $88 |
| Atorvastatin | 110 | $907 | $8 |
| Losartan | 41 | $683 | $17 |
| Levothyroxine | 52 | $665 | $13 |
| Rosuvastatin | 20 | $592 | $30 |
| Escitalopram | 22 | $564 | $26 |
| Albuterol Sulfate Hfa | 23 | $485 | $21 |
| Amlodipine Besylate | 75 | $404 | $5 |
| Triamterene-Hydrochlorothiazid | 16 | $295 | $18 |
| Metoprolol | 13 | $226 | $17 |
| Sertraline | 16 | $221 | $14 |
| Fluticasone Propionate | 16 | $212 | $13 |
| Lisinopril | 43 | $207 | $5 |
| Metformin | 36 | $195 | $5 |
| Pantoprazole | 20 | $192 | $10 |
| Baclofen | 11 | $145 | $13 |
| Famotidine | 11 | $117 | $11 |
| Hydrochlorothiazide | 14 | $95 | $7 |
| Cyclobenzaprine | 12 | $84 | $7 |
| Hydroxyzine | 13 | $66 | $5 |
| Sumatriptan | 11 | $63 | $6 |
| Quetiapine | 11 | $59 | $5 |
| Simvastatin | 19 | $46 | $2 |
| Naproxen | 15 | $36 | $2 |
| Meloxicam | 13 | $15 | $1 |
Year by year
| 2024 | 1,005 | 146 | 1% (12) | None | $69,745 |
| 2023 | 952 | 151 | 4% (33) | 11% | $58,609 |
| 2022 | 1,015 | 155 | 5% (50) | 10% | $76,742 |
| 2021 | 818 | 114 | 2% (14) | None | $52,219 |
| 2020 | 309 | 74 | None | 20% | $18,264 |
| 2019 | 48 | 18 | 0% (0) | None | $2,605 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 21 drugs
| Eliquis | 18 | $15,026 | $835 |
| Rosuvastatin | 22 | $1,759 | $80 |
| Atorvastatin | 99 | $1,148 | $12 |
| Levothyroxine | 47 | $1,130 | $24 |
| Losartan | 37 | $787 | $21 |
| Albuterol Sulfate Hfa | 21 | $682 | $32 |
| Escitalopram | 28 | $660 | $24 |
| Duloxetine | 14 | $648 | $46 |
| Amlodipine Besylate | 61 | $609 | $10 |
| Metformin | 34 | $510 | $15 |
| Hydrocodone-Acetaminophen | 27 | $455 | $17 |
| Fluticasone Propionate | 11 | $437 | $40 |
| Lisinopril | 41 | $417 | $10 |
| Triamterene-Hydrochlorothiazid | 17 | $380 | $22 |
| Gabapentin | 16 | $331 | $21 |
| Pantoprazole | 17 | $300 | $18 |
| Tamsulosin | 13 | $281 | $22 |
| Naproxen | 11 | $152 | $14 |
| Simvastatin | 21 | $98 | $5 |
| Celecoxib | 13 | $91 | $7 |
| Lorazepam | 13 | $42 | $3 |
2022: 24 drugs
| Eliquis | 16 | $17,050 | $1,066 |
| Rosuvastatin | 11 | $1,409 | $128 |
| Atorvastatin | 78 | $1,116 | $14 |
| Losartan-Hydrochlorothiazide | 12 | $851 | $71 |
| Amlodipine Besylate | 64 | $757 | $12 |
| Levothyroxine | 41 | $623 | $15 |
| Duloxetine | 25 | $579 | $23 |
| Pantoprazole | 26 | $514 | $20 |
| Losartan | 40 | $473 | $12 |
| Omeprazole | 22 | $443 | $20 |
| Metformin | 33 | $415 | $13 |
| Hydrocodone-Acetaminophen | 34 | $380 | $11 |
| Lisinopril | 38 | $344 | $9 |
| Albuterol Sulfate Hfa | 11 | $302 | $27 |
| Escitalopram | 15 | $300 | $20 |
| Simvastatin | 29 | $299 | $10 |
| Hydrochlorothiazide | 19 | $232 | $12 |
| Famotidine | 16 | $219 | $14 |
| Gabapentin | 20 | $190 | $10 |
| Cyclobenzaprine | 15 | $185 | $12 |
| Metoprolol | 13 | $162 | $12 |
| Tramadol | 12 | $99 | $8 |
| Lorazepam | 17 | $97 | $6 |
| Clonazepam | 12 | $52 | $4 |
2021: 17 drugs
| Pantoprazole | 38 | $830 | $22 |
| Atorvastatin | 49 | $708 | $14 |
| Levothyroxine | 37 | $643 | $17 |
| Losartan | 27 | $542 | $20 |
| Amlodipine Besylate | 60 | $490 | $8 |
| Tamsulosin | 30 | $403 | $13 |
| Gabapentin | 21 | $298 | $14 |
| Duloxetine | 15 | $273 | $18 |
| Lovastatin | 18 | $271 | $15 |
| Metformin | 27 | $243 | $9 |
| Omeprazole | 12 | $230 | $19 |
| Hydrochlorothiazide | 21 | $208 | $10 |
| Lisinopril | 33 | $207 | $6 |
| Escitalopram | 17 | $198 | $12 |
| Atenolol | 12 | $197 | $16 |
| Finasteride | 15 | $177 | $12 |
| Simvastatin | 18 | $162 | $9 |
2020: 7 drugs
| Levothyroxine | 24 | $432 | $18 |
| Atorvastatin | 16 | $304 | $19 |
| Pantoprazole | 14 | $295 | $21 |
| Duloxetine | 11 | $218 | $20 |
| Amlodipine Besylate | 15 | $192 | $13 |
| Omeprazole | 11 | $102 | $9 |
| Lisinopril | 12 | $93 | $8 |
Money from drug and device companies
$23 in 2022
A payment is not proof that care is biased.
| Iti | Caplyta | $23 | 1 payment
|
See the published payment
| Iti | Meals · 2022-10-26 | Caplyta | $23 |
Professional record
- NPI
- 1427403146
- Licence
- CA A155899California A155899: Current · expires 2028-05-31
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2016-05-01
- NPI last updated
- 2020-06-03
- NPI record certified
- 2020-06-03
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 2351 Clay St, San Francisco, CA, 94115